Renalytix AI plc
("Renalytix" or the "Company")
Clarification re. lock-up restrictions for Distribution Shares
This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the "Distribution Shares").
Holders of Distribution Shares are reminded that these shares remain subject to a lock-up restriction until 22 April 2019. To avoid settlement issues and potentially having to repurchase such shares in the market, such persons should therefore avoid attempting to sell Distribution Shares until Tuesday, 23 April 2019 or afterwards.
For further information, please contact:
|
Renalytix AI plc |
||
|
James McCullough, CEO |
Via Walbrook PR or Tel: +1 646 397 3970 |
|
|
|
|
|
|
N+1 Singer (Nominated Adviser & Broker) |
Tel: 020 7496 3000 |
|
|
Aubrey Powell / James White / George Tzimas (Corporate Finance) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or renalytix@walbrookpr.com |
|
|
Paul McManus / Lianne Cawthorne |
Mob: 07980 541 893 / 07584 391 303 |
|